Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Virol J ; 13(1): 163, 2016 10 03.
Artículo en Inglés | MEDLINE | ID: mdl-27716429

RESUMEN

BACKGROUND: Sub-Saharan Africa is home to a variety of pathogens, but disease surveillance and the healthcare infrastructure necessary for proper management and control are severely limited. Lassa virus, the cause of Lassa fever, a severe hemorrhagic fever in humans is endemic in West Africa. In Sierra Leone at the Kenema Government Hospital Lassa Diagnostic Laboratory, up to 70 % of acute patient samples suspected of Lassa fever test negative for Lassa virus infection. This large amount of acute undiagnosed febrile illness can be attributed in part to an array of hemorrhagic fever and arthropod-borne viruses causing disease that goes undetected and untreated. METHODS: To better define the nature and extent of viral pathogens infecting the Sierra Leonean population, we developed a multiplexed MAGPIX® assay to detect IgG antibodies against Lassa, Ebola, Marburg, Rift Valley fever, and Crimean-Congo hemorrhagic fever viruses as well as pan-assays for flaviviruses and alphaviruses. This assay was used to survey 675 human serum samples submitted to the Lassa Diagnostic Laboratory between 2007 and 2014. RESULTS: In the study population, 50.2 % were positive for Lassa virus, 5.2 % for Ebola virus, 10.7 % for Marburg virus, 1.8 % for Rift Valley fever virus, 2.0 % for Crimean-Congo hemorrhagic fever virus, 52.9 % for flaviviruses and 55.8 % for alphaviruses. CONCLUSIONS: These data exemplify the importance of disease surveillance and differential diagnosis for viral diseases in Sierra Leone. We demonstrate the endemic nature of some of these viral pathogens in the region and suggest that unrecognized outbreaks of viral infection have occurred.


Asunto(s)
Anticuerpos Antivirales/sangre , Virosis/epidemiología , Brotes de Enfermedades , Enfermedades Endémicas , Monitoreo Epidemiológico , Humanos , Inmunoensayo/métodos , Estudios Seroepidemiológicos , Sierra Leona/epidemiología , Virosis/virología
2.
Nat Commun ; 11(1): 510, 2020 01 24.
Artículo en Inglés | MEDLINE | ID: mdl-31980636

RESUMEN

Marburg virus (MARV) causes sporadic outbreaks of severe Marburg virus disease (MVD). Most MVD outbreaks originated in East Africa and field studies in East Africa, South Africa, Zambia, and Gabon identified the Egyptian rousette bat (ERB; Rousettus aegyptiacus) as a natural reservoir. However, the largest recorded MVD outbreak with the highest case-fatality ratio happened in 2005 in Angola, where direct spillover from bats was not  shown. Here, collaborative studies by the Centers for Disease Control and Prevention, Njala University, University of California, Davis USAID-PREDICT, and the University of Makeni identify MARV circulating in ERBs in Sierra Leone. PCR, antibody and virus isolation data from 1755 bats of 42 species shows active MARV infection in approximately 2.5% of ERBs. Phylogenetic analysis identifies MARVs that are similar to the Angola strain. These results provide evidence of MARV circulation in West Africa and demonstrate the value of pathogen surveillance to identify previously undetected threats.


Asunto(s)
Quirópteros/virología , Marburgvirus/aislamiento & purificación , África Occidental , Animales , Cuevas , Genoma Viral , Geografía , Funciones de Verosimilitud , Enfermedad del Virus de Marburg/virología , Marburgvirus/clasificación , Marburgvirus/genética , Filogenia , Análisis de Secuencia de ADN , Proteínas Virales/metabolismo
3.
EBioMedicine ; 40: 605-613, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30711514

RESUMEN

BACKGROUND: Lassa virus (LASV) is the etiologic agent of an acute hemorrhagic fever endemic in West Africa. Natural killer (NK) cells control viral infections in part through the interaction between killer cell immunoglobulin-like receptors (KIRs) and their ligands. LASV infection is associated with defective immune responses, including inhibition of NK cell activity in the presence of MHC-class 1+-infected target cells. METHODS: We compared individual KIR and HLA-class 1 genotypes of 68 healthy volunteers to 51 patients infected with LASV in Sierra Leone, including 37 survivors and 14 fatalities. Next, potential HLA-C1, HLA-C2, and HLA-Bw4 binding epitopes were in silico screened among LASV nucleoprotein (NP) and envelope glycoprotein (GP). Selected 10-mer peptides were then tested in peptide-HLA stabilization, KIR binding and polyfunction assays. FINDINGS: LASV-infected patients were similar to healthy controls, except for the inhibitory KIR2DL2 gene. We found a specific increase in the HLA-C1:KIR2DL2 interaction in fatalities (10/11) as compared to survivors (12/19) and controls (19/29). We also identified that strong of NP and GP viral epitopes was only observed with HLA-C molecules, and associated with strong inhibition of degranulation in the presence of KIR2DL+ NK cells. This inhibitory effect significantly increased in the presence of the vGP420 variant, detected in 28.1% of LASV sequences. INTERPRETATION: Our finding suggests that presentation of specific LASV epitopes by HLA-C alleles to the inhibitory KIR2DL2 receptor on NK cells could potentially prevent the killing of infected cells and provides insights into the mechanisms by which LASV can escape NK-cell-mediated immune pressure.


Asunto(s)
Epítopos/inmunología , Antígenos HLA-C/inmunología , Células Asesinas Naturales/inmunología , Células Asesinas Naturales/metabolismo , Fiebre de Lassa/inmunología , Fiebre de Lassa/metabolismo , Virus Lassa/inmunología , Receptores KIR2DL2/metabolismo , Antígenos Virales/inmunología , Línea Celular , Citotoxicidad Inmunológica , Mapeo Epitopo/métodos , Genotipo , Antígenos HLA-C/genética , Humanos , Tolerancia Inmunológica , Inmunomodulación , Inmunofenotipificación , Fiebre de Lassa/genética , Fiebre de Lassa/virología , Unión Proteica , Receptores KIR2DL2/genética
4.
Sci Rep ; 8(1): 6480, 2018 04 24.
Artículo en Inglés | MEDLINE | ID: mdl-29691416

RESUMEN

Ebola virus (EBOV) is a negative-strand RNA virus that replicates in the cytoplasm and causes an often-fatal hemorrhagic fever. EBOV, like other viruses, can reportedly encode its own microRNAs (miRNAs) to subvert host immune defenses. miRNAs are short noncoding RNAs that can regulate gene expression by hybridizing to multiple mRNAs, and viral miRNAs can enhance viral replication and infectivity by regulating host or viral genes. To date, only one EBOV miRNA has been examined in human infection. Here, we assayed mouse, rhesus macaque, cynomolgus macaque, and human samples infected with three EBOV variants for twelve computationally predicted viral miRNAs using RT-qPCR. Ten miRNAs aligned to EBOV variants and were detectable in the four species during disease with several viral miRNAs showing presymptomatic amplification in animal models. miRNA abundances in both the mouse and nonhuman primate models mirrored the human cohort, with miR-1-5p, miR-1-3p, and miR-T3-3p consistently at the highest levels. These striking similarities in the most abundant miRNAs during infection with different EBOV variants and hosts indicate that these miRNAs are potential valuable diagnostic markers and key effectors of EBOV pathogenesis.


Asunto(s)
Ebolavirus/genética , Fiebre Hemorrágica Ebola/genética , MicroARNs/genética , Animales , Expresión Génica/genética , Perfilación de la Expresión Génica/métodos , Fiebre Hemorrágica Ebola/virología , Humanos , Macaca fascicularis/genética , Macaca mulatta/genética , Ratones , ARN Mensajero/metabolismo , Replicación Viral/genética
5.
Sci Rep ; 6: 24496, 2016 Apr 21.
Artículo en Inglés | MEDLINE | ID: mdl-27098369

RESUMEN

Early detection of Ebola virus (EBOV) infection is essential to halting transmission and adjudicating appropriate treatment. However, current methods rely on viral identification, and this approach can misdiagnose presymptomatic and asymptomatic individuals. In contrast, disease-driven alterations in the host transcriptome can be exploited for pathogen-specific diagnostic biomarkers. Here, we present for the first time EBOV-induced changes in circulating miRNA populations of nonhuman primates (NHPs) and humans. We retrospectively profiled longitudinally-collected plasma samples from rhesus macaques challenged via intramuscular and aerosol routes and found 36 miRNAs differentially present in both groups. Comparison of miRNA abundances to viral loads uncovered 15 highly correlated miRNAs common to EBOV-infected NHPs and humans. As proof of principle, we developed an eight-miRNA classifier that correctly categorized infection status in 64/74 (86%) human and NHP samples. The classifier identified acute infections in 27/29 (93.1%) samples and in 6/12 (50%) presymptomatic NHPs. These findings showed applicability of NHP-derived miRNAs to a human cohort, and with additional research the resulting classifiers could impact the current capability to diagnose presymptomatic and asymptomatic EBOV infections.


Asunto(s)
Ebolavirus/fisiología , Fiebre Hemorrágica Ebola/genética , Fiebre Hemorrágica Ebola/virología , Interacciones Huésped-Patógeno/genética , MicroARNs/genética , Adolescente , Adulto , Animales , Biomarcadores , Análisis por Conglomerados , Biología Computacional/métodos , Modelos Animales de Enfermedad , Femenino , Perfilación de la Expresión Génica , Fiebre Hemorrágica Ebola/sangre , Fiebre Hemorrágica Ebola/diagnóstico , Humanos , Macaca mulatta , Masculino , MicroARNs/sangre , Persona de Mediana Edad , Carga Viral , Adulto Joven
6.
Comput Math Methods Med ; 2015: 736507, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25755674

RESUMEN

We present a stochastic transmission chain simulation model for Ebola viral disease (EVD) in West Africa, with the salutary result that the virus may be more controllable than previously suspected. The ongoing tactics to detect cases as rapidly as possible and isolate individuals as safely as practicable is essential to saving lives in the current outbreaks in Guinea, Liberia, and Sierra Leone. Equally important are educational campaigns that reduce contact rates between susceptible and infectious individuals in the community once an outbreak occurs. However, due to the relatively low R 0 of Ebola (around 1.5 to 2.5 next generation cases are produced per current generation case in naïve populations), rapid isolation of infectious individuals proves to be highly efficacious in containing outbreaks in new areas, while vaccination programs, even with low efficacy vaccines, can be decisive in curbing future outbreaks in areas where the Ebola virus is maintained in reservoir populations.


Asunto(s)
Control de Enfermedades Transmisibles/métodos , Brotes de Enfermedades/prevención & control , Fiebre Hemorrágica Ebola/prevención & control , Fiebre Hemorrágica Ebola/terapia , Fiebre Hemorrágica Ebola/transmisión , Programas de Inmunización/métodos , Algoritmos , Simulación por Computador , Vacunas contra el Virus del Ébola/uso terapéutico , Ebolavirus , Epidemias , Guinea , Fiebre Hemorrágica Ebola/epidemiología , Humanos , Liberia , Cadenas de Markov , Modelos Teóricos , Aislamiento de Pacientes , Sierra Leona , Programas Informáticos , Procesos Estocásticos , Vacunación
8.
PLoS Curr ; 72015 Apr 20.
Artículo en Inglés | MEDLINE | ID: mdl-25969797

RESUMEN

Since Ebola Virus Disease (EVD) was first identified in 1976 in what is now the Democratic Republic of Congo, and despite the numerous outbreaks recorded to date, rarely has an epidemic origin been identified. Indeed, among the twenty-one most documented EVD outbreaks in Africa, an index case has been identified four times, and hypothesized in only two other instances. The initial steps of emergence and spread of a virus are critical in the development of a potential outbreak and need to be thoroughly dissected and understood in order to improve on preventative strategies. In the current West African outbreak of EVD, a unique index case has been identified, pinpointing the geographical origin of the epidemic in Guinea. Herein, we provide an accounting of events that serve as the footprint of EVD emergence in Sierra Leone and a road map for risk mitigation fueled by lessons learned.

9.
Science ; 345(6202): 1369-72, 2014 Sep 12.
Artículo en Inglés | MEDLINE | ID: mdl-25214632

RESUMEN

In its largest outbreak, Ebola virus disease is spreading through Guinea, Liberia, Sierra Leone, and Nigeria. We sequenced 99 Ebola virus genomes from 78 patients in Sierra Leone to ~2000× coverage. We observed a rapid accumulation of interhost and intrahost genetic variation, allowing us to characterize patterns of viral transmission over the initial weeks of the epidemic. This West African variant likely diverged from central African lineages around 2004, crossed from Guinea to Sierra Leone in May 2014, and has exhibited sustained human-to-human transmission subsequently, with no evidence of additional zoonotic sources. Because many of the mutations alter protein sequences and other biologically meaningful targets, they should be monitored for impact on diagnostics, vaccines, and therapies critical to outbreak response.


Asunto(s)
Brotes de Enfermedades , Ebolavirus/genética , Monitoreo Epidemiológico , Fiebre Hemorrágica Ebola/transmisión , Fiebre Hemorrágica Ebola/virología , Secuencia de Bases , Ebolavirus/aislamiento & purificación , Variación Genética , Genoma Viral/genética , Genómica/métodos , Fiebre Hemorrágica Ebola/epidemiología , Humanos , Mutación , Análisis de Secuencia de ADN , Sierra Leona/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA